Research

#Biotechnology #Drug discovery #Genetics / genomes #Genetics / genomics #Research

Francis Crick Institute and GSK to pioneer reactive fragment screening

Researchers at the Francis Crick Institute and GSK are extending their collaboration to advance the discovery of new drug targets in a £11.5 million effort. This comes after receiving a ‘Prosperity Partnership’ grant from the Engineering and Physical Sciences Research Council (EPSRC) and matching funds from GSK. Together, the teams… Read More

#News

#Cancer research #Covid-19 #Institute of Cancer Research #Research

Funding cuts could capsize cancer research in the UK

Cancer research in the UK is at risk through a combination of proposed government funding cuts for UK science and the impact of the pandemic on charity funding, warns a leading cancer research institute. The Institute of Cancer Research (ICR) is revealing reductions of as much as a fifth in… Read More

#Cancer Research #News

#Animal testing #Clinical trials #Covid-19 #Research

68% of Britons want end to animal testing in UK labs

Over two-thirds of Britons want an end to animal experiments in medical research in UK labs, a new poll reveals. The YouGov survey, carried out on behalf of charity Animal Free Research UK, showed strong public support for ending animal experiments and replacing them with non-animal alternatives, such as artificial… Read More

#News

#Assay #Bioscience #Biotechnology #Drug development #Kinetics #Research #Screening #Video

NanoBRET technology enables the study of the interaction of compounds

Aurelia Bioscience is a pre-clinical contract research organisation specialising in bioassay development, pharmacological profiling and compound screening. Scientists at Aurelia Bioscience have experience developing new and innovative bio-assays for different target classes using technologies to deliver client projects in a timely, efficient and cost-effective manner. Using Promega’s NanoBRET… Read More

#News #Videos

#Covid-19 #Immunology / Virology & Vaccines #Podcast #Research

Vaccine innovation in the age of Covid-19 – podcast

The latest free to listen to DDW podcast episode, Vaccine innovation in the age of Covid-19, covers two articles written for DDW and read aloud by DDW Editorial Assistant, Megan Thomas. These articles are titled: “Vaccine innovation in the age of Covid-19 & beyond” and “Creating vaccines: Why we should… Read More

#News

#Covid-19 #Drug development #Immunology / Virology & Vaccines #Research

Modelling and simulation facilitates drug repurposing to counter Covid-19

By Dr Craig R. Rayner, FRCP Edin, PharmD, MBA, President, Integrated Drug Development at Certara Right at the start of the Covid-19 pandemic, medical researchers began questioning whether there were any existing, on-market drugs that might prove effective against SARS-CoV-2. They wanted to offer healthcare professionals and patients some known… Read More

#Business & Investment #Exclusive Content #News

#Dementia #Drug development #Drug discovery #Muscles #Research

Scientists study how signals from muscles can protect from dementia

Scientists at St. Jude Children’s Research Hospital are studying how signals sent from skeletal muscle affect the brain. The team studied fruit flies and brain cell models called organoids, focusing on the signals that muscles send when stressed. They used immunostaining and confocal microscopy on the fruit fly brain and… Read More

#News

#Cancer research #Covid-19 #Immunology / Virology & Vaccines #Research

Cancer drug lessens toxicity of protein from virus that causes Covid-19

The University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2 and then used an FDA-approved cancer drug to blunt the viral protein’s detrimental effects. In experiments in fruit flies and human cell lines, the team discovered the cell process that the virus… Read More

#Cancer Research #Covid-19 #News

#Antibody #Cancer #Cancer research #Immune cells #Research

Cancer immunotherapy may also treat autoimmune diseases

A team of researchers has found disrupting the interaction between cancer cells and certain immune cells is more effective at killing cancer cells than current immunotherapy treatments. The findings, which include studies in cell lines and animal models, appeared in JCI Insight and focus on a protein called CD6 as… Read More

#Cancer Research #News

#Drug delivery #Drug development #Drug discovery #Research

Russian scientists’ to help create targeted drug delivery capsules

Scientists from MIPT and ITMO University and their colleagues have studied the formation and growth of crystals from simple organic molecules into large associations, which may help create capsules for targeted drug delivery to specific tissues in the human body. The scientific paper was published in the journal Crystal Growth… Read More

#News

#Clinical trials #Covid-19 #Drug development #Drug discovery #Research

Hormone drugs may disarm COVID-19 spike protein

Researchers in the Abramson Cancer Center at the University of Pennsylvania have published a new preclinical study which found hormone drugs that reduce androgen levels may help disarm the coronavirus spike protein used to infect cells and stop the progression of severe COVID-19 disease. The study, published online in Cell Press’s iScience, showed how two… Read More

#Covid-19 #News

#Assay #Assay development optimisation & technology #Drug discovery #Research

BellBrook Labs given NIH funding for work on antitumour immunity 

Drug discovery company BellBrook Labs has been awarded a $300,000 Phase I Small Business Innovative Research grant to develop and validate HTS assays for the discovery of small-molecule antagonists of TREX1. Immunotherapy approaches such as immune checkpoint blockade are said to be transforming oncology. However, many patients do not respond to… Read More

#News

#Autoimmune disease #Research #Study

Study explains why autoimmune diseases affect women more than men

A study led by an international team of researchers has made an important breakthrough in terms of understanding the causes of primary biliary cholangitis (PBC). The programme was coordinated by experts from the University of Milano-Bicocca and the Autoimmune Diseases of the Liver Centre at the San Gerardo Hospital in Monza,… Read More

#News

#Covid-19 #Immunology / Virology & Vaccines #Research

Oxford University leads first trial into dosing with alternating vaccines

The University of Oxford has reported  it is to lead the first trial looking into alternating different COVID-19 vaccines, to explore the potential for flexibility in delivery and look for clues as to how to increase the breadth of protection against new virus strains. The study, run by the National… Read More

#Covid-19 #Editor's Choice #News #Trending News

#AI / data analytics / healthtech / informatics #Assay development optimisation & technology #Drug development #Drug discovery #Narrated podcasts #Research

Innovation and Opportunity in Drug Discovery

Today’s episode on the topic of Innovation and Opportunity in Drug Discovery, covers 3 articles taken from the most recent Fall issue of DDW. These articles are titled: Japanese drug development: Where is the innovation, Where are the opportunities in global drug discovery, and New for Old: The value behind drug repurposing. These… Read More

#Podcasts